We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.85%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
GE
26
General Electric
Ohio
$467M +$216M +963,306 +99%
SIG
27
Senator Investment Group
New York
$457M +$43.2M +193,100 +11%
APG Asset Management
28
APG Asset Management
Netherlands
$444M +$122M +546,456 +42%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$441M -$10.2M -45,587 -2%
DCM
30
Discovery Capital Management
Connecticut
$440M +$301M +1,346,016 +282%
Norges Bank
31
Norges Bank
Norway
$432M -$122M -545,184 -23%
BRC
32
Blue Ridge Capital
New York
$419M
GCM
33
Glenview Capital Management
New York
$414M +$384M +1,717,858 New
Invesco
34
Invesco
Georgia
$402M -$10.6M -47,475 -3%
JP Morgan Chase
35
JP Morgan Chase
New York
$391M +$160M +716,749 +79%
FAM
36
Fred Alger Management
New York
$384M +$76.7M +342,716 +27%
Citadel Advisors
37
Citadel Advisors
Florida
$378M +$123M +548,368 +54%
PI
38
Putnam Investments
Massachusetts
$357M -$3.21M -14,349 -1%
O
39
OrbiMed
New York
$347M +$202M +904,200 +170%
CM
40
Corvex Management
New York
$337M +$49M +218,990 +19%
BlackRock
41
BlackRock
New York
$314M +$110M +490,359 +61%
Goldman Sachs
42
Goldman Sachs
New York
$305M +$41M +183,085 +17%
YCMGA
43
York Capital Management Global Advisors
New York
$302M +$280M +1,250,962 New
Bank of America
44
Bank of America
North Carolina
$297M -$8.01M -35,791 -3%
SCM
45
Steadfast Capital Management
New York
$287M -$123M -550,545 -32%
BA
46
BlackRock Advisors
Delaware
$281M +$194M +869,091 +292%
PC
47
Paulson & Co
New York
$256M +$171M +762,200 +254%
WBC
48
Westpac Banking Corp
Australia
$256M +$2.47M +11,050 +1%
Westfield Capital Management
49
Westfield Capital Management
Massachusetts
$254M -$89.8M -401,432 -28%
AIM
50
Assured Investment Management
New York
$254M +$30.8M +137,576 +15%

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.